These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16410681)

  • 1. Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis.
    Vamvakopoulos JE; Petrov L; Aavik S; Lehti S; Aavik E; Hayry P
    J Vasc Res; 2006; 43(2):184-92. PubMed ID: 16410681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms behind the synergistic effect of sirolimus and imatinib in preventing restenosis after intimal injury.
    Tigerstedt NM; Aavik E; Lehti S; Hayry P; Savolainen-Peltonen H
    J Vasc Res; 2009; 46(3):240-52. PubMed ID: 18984963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: is there a window of opportunity for systemic prophylaxis of restenosis?
    Jahnke T; Schäfer FK; Bolte H; Heuer G; Karbe U; Brossmann J; Brandt M; Heller M; Müller-Hülsbeck S
    J Endovasc Ther; 2005 Jun; 12(3):332-42. PubMed ID: 15943508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury.
    Makiyama Y; Toba K; Kato K; Hirono S; Ozawa T; Saigawa T; Minagawa S; Isoda M; Asami F; Ikarashi N; Oda M; Moriyama M; Higashimura M; Kitajima T; Otaki K; Aizawa Y
    Tohoku J Exp Med; 2008 Aug; 215(4):299-306. PubMed ID: 18679003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate: clinical results in Philadelphia chromosome-positive leukemias.
    Kantarjian HM; Talpaz M
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):9-18. PubMed ID: 11740802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
    Sillaber C; Mayerhofer M; Böhm A; Vales A; Gruze A; Aichberger KJ; Esterbauer H; Pfeilstöcker M; Sperr WR; Pickl WF; Haas OA; Valent P
    Eur J Clin Invest; 2008 Jan; 38(1):43-52. PubMed ID: 18173550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue.
    Ozgur-Akdemir A; Demirturk K; Karabakan M; Volkan-Oztekin C; Abdulkadir NA; Cetinkaya M; Gur S; Hellstrom WJ
    Urology; 2011 Oct; 78(4):968.e1-6. PubMed ID: 21872909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
    Payne SM; Kovacs MJ
    Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts.
    Eckl S; Heim C; Abele-Ohl S; Hoffmann J; Ramsperger-Gleixner M; Weyand M; Ensminger SM
    Transpl Int; 2010 Sep; 23(9):959-66. PubMed ID: 20230539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone.
    Wang JR; Yen CC; Gau JP; Hsiao LT; Liu CY; Pai JT; Tzeng CH; Teng HW
    J Clin Pharm Ther; 2010 Dec; 35(6):733-6. PubMed ID: 21054467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
    Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
    J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
    Demetri GD; von Mehren M; Blanke CD; Van den Abbeele AD; Eisenberg B; Roberts PJ; Heinrich MC; Tuveson DA; Singer S; Janicek M; Fletcher JA; Silverman SG; Silberman SL; Capdeville R; Kiese B; Peng B; Dimitrijevic S; Druker BJ; Corless C; Fletcher CD; Joensuu H
    N Engl J Med; 2002 Aug; 347(7):472-80. PubMed ID: 12181401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits.
    Leppänen O; Rutanen J; Hiltunen MO; Rissanen TT; Turunen MP; Sjöblom T; Brüggen J; Bäckström G; Carlsson M; Buchdunger E; Bergqvist D; Alitalo K; Heldin CH; Ostman A; Ylä-Herttuala S
    Circulation; 2004 Mar; 109(9):1140-6. PubMed ID: 14769706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia].
    Voglová J; Poznarová A; Chrobák L; Rabasová J; Beránek M; Moravcová J; Faber E; Klamová H; Cikhart M
    Vnitr Lek; 2004 Jan; 50(1):21-3, 26-9. PubMed ID: 15015226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
    Cohen MH; Williams G; Johnson JR; Duan J; Gobburu J; Rahman A; Benson K; Leighton J; Kim SK; Wood R; Rothmann M; Chen G; U KM; Staten AM; Pazdur R
    Clin Cancer Res; 2002 May; 8(5):935-42. PubMed ID: 12006504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.